黑色素瘤患者自我报告结局的评估
Assessment of patient-reported outcomes in patients with melanoma.
作者信息
Cormier Janice N, Askew Robert L
机构信息
Department of Surgical Oncology, Unit 444, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
出版信息
Surg Oncol Clin N Am. 2011 Jan;20(1):201-13. doi: 10.1016/j.soc.2010.09.002.
Assessment of patient-reported outcomes (PROs) provides important information to assist with clinical decision making. There has been significant progress in the field of PROs over the past 2 decades with the introduction of validated disease- and symptom-specific instruments. The Functional Assessment of Cancer Therapy-Melanoma (FACT-M) is a melanoma-specific module to accompany the FACT-General, which was validated to assess health-related quality of life for patients with all stages of melanoma. Melanoma-specific health state utilities also have been reported from a number of studies. Assessment of PROs should be incorporated into routine clinical practice to inform clinicians and researchers of the patient perspective for clinical decision making and to evaluate the effects of psychosocial and medical interventions.
患者报告结局（PROs）评估为临床决策提供重要信息。在过去20年里，随着经过验证的疾病和症状特异性工具的引入，PROs领域取得了重大进展。癌症治疗功能评估-黑色素瘤（FACT-M）是FACT通用量表的黑色素瘤特异性模块，经验证可用于评估各阶段黑色素瘤患者的健康相关生活质量。多项研究还报告了黑色素瘤特异性健康状态效用值。PROs评估应纳入常规临床实践，以便为临床医生和研究人员提供患者视角的信息，用于临床决策，并评估心理社会和医学干预的效果。
Zotero 插件